AXQ Capital’s Tandem Diabetes Care TNDM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q2
Sell
-10,098
Closed -$193K 781
2025
Q1
$193K Buy
+10,098
New +$296K 0.08% 402
2024
Q3
Sell
-12,372
Closed -$498K 602
2024
Q2
$498K Buy
+12,372
New +$516K 0.12% 298
2023
Q2
Sell
-17,184
Closed -$698K 555
2023
Q1
$698K Buy
+17,184
New +$711K 0.28% 109

Other funds holding TNDM

AXQ Capital's TNDM Position: Q2 2025 in Review

AXQ Capital sold out of Tandem Diabetes Care (TNDM) in Q2 2025, closing a stake of 10,098 shares — an estimated $193K sold.

AXQ Capital first reported a position in TNDM in Q1 2023 and held it in 3 quarters. The position peaked at $698K in Q1 2023. 270 funds tracked by Wall St. Rank hold TNDM as of Q2 2025.

  • AXQ Capital reported no remaining Tandem Diabetes Care position as of Q2 2025 after selling out during the quarter.
  • AXQ Capital sold 10,098 Tandem Diabetes Care shares in Q2 2025, an estimated $193K.
  • AXQ Capital first reported a position in Tandem Diabetes Care in Q1 2023 and held it in 3 quarters.
  • AXQ Capital's Tandem Diabetes Care position peaked at $698K in Q1 2023.
  • 270 funds tracked by Wall St. Rank held Tandem Diabetes Care as of Q2 2025.

Based on AXQ Capital's 13F filing for Q2 2025, filed 12 Aug 2025.